ArticleJournal for immunotherapy of cancer2021

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.

Alessio Cortellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.